* An outpatient clinical research study will compare the efficacy of
Risperidone and Haloperidol in clients diagnosed with schizophrenia and
schizoaffective disorder. Both are FDA approved, effective medications.
This is a double-blind study lasting up to two years. There is no placebo
group. The study will be conducted in Bellevue Hospital Center, Dept. of
For more information please contact James C.-Y. Chou, M.D., or Nancy
Richardson at (212) 562-7310 or (212) 263-6203.
[ Home] [News]